ImmunityBio (IBRX) Interest Coverage Ratio (2016 - 2026)

ImmunityBio (IBRX) has 10 years of Interest Coverage Ratio data on file, last reported at 4.78 in Q1 2026.

• Interest Coverage Ratio for Q1 2026 came in at 4.78, down 13.67% year-over-year; the trailing twelve-month figure through Mar 2026 was 4.34 (down 39.23% YoY), and the FY2025 annual result was 4.21, down 40.0% from the prior year.
• Interest Coverage Ratio slipped to 4.78 in Q1 2026 per IBRX's latest filing, from 4.36 in the prior quarter.
• Over five years, Interest Coverage Ratio peaked at 4.55 in Q4 2022 and troughed at 213.47 in Q4 2023.
• A 5-year average of 16.24 and a median of 3.74 in 2023 frame the typical range for Interest Coverage Ratio.
• The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio surged 125.78% in 2022, then tumbled 4790.11% in 2023.
• A 5-year view of Interest Coverage Ratio shows it stood at 4.55 in 2022, then plunged by 4790.11% to 213.47 in 2023, then jumped by 98.75% to 2.67 in 2024, then plunged by 63.39% to 4.36 in 2025, then fell by 9.75% to 4.78 in 2026.
• Business Quant data shows IBRX's Interest Coverage Ratio at 4.78 in Q1 2026, 4.36 in Q4 2025, and 3.65 in Q3 2025.